Fortress Biotech, Inc.
(NASDAQ : FBIO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 0.00%333.600.0%$4452.92m
BNTXBioNTech SE 2.66%269.850.0%$742.47m
NVAXNovavax, Inc. -15.31%135.9779.4%$602.21m
AMGNAmgen, Inc. 1.40%209.681.4%$553.98m
SNSSSunesis Pharmaceuticals, Inc. 4.81%6.440.7%$450.18m
REGNRegeneron Pharmaceuticals, Inc. 1.65%561.212.7%$438.69m
GILDGilead Sciences, Inc. 0.28%67.091.0%$414.23m
CCXIChemoCentryx, Inc. 2.85%34.612.9%$396.34m
ILMNIllumina, Inc. -0.18%413.343.3%$373.95m
XLRNAcceleron Pharma, Inc. -0.53%172.835.3%$348.49m
VRTXVertex Pharmaceuticals, Inc. 0.35%186.061.9%$270.71m
BIIBBiogen, Inc. -0.32%267.271.7%$242.75m
OCGNOcugen, Inc. 5.28%8.770.0%$185.73m
XENEXenon Pharmaceuticals, Inc. 1.68%30.310.4%$163.06m
CRSPCRISPR Therapeutics AG -1.66%98.600.6%$159.44m

Company Profile

Fortress Biotech, Inc. engages in the manufacture and commercialization of novel pharmaceutical products and product candidates. It operates through the following Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development segments. Its products include Ximino, Targadox, Exelderm, Ceracade, and Luxamend. The company was founded on June 28, 2006 and is headquartered in New York, NY.